# Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices

> **NCT01970748** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 200 (estimated)

## Conditions studied

- Bleeding Esophageal Varices
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Propranolol
- **PROCEDURE:** Esophageal variceal ligation

## Key facts

- **NCT ID:** NCT01970748
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2023-12-25
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970748, "Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01970748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*